NDC 17856-0672-01 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0672
- Requested NDC
- 17856-0672-01
- Package NDCs from labels
- 17856-0672-1, 17856-0672-2, 17856-0672-3, 17856-0672-4, 17856-0672-01
- Manufacturer
- Atlantic Biologics Corp.
- Effective date
- 2025-10-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Atlantic Biologics Corp. | Atlantic Biologics Corp. | 2025-10-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0672-1 | Ondansetron | 60 in 1 CASE | SOLUTION | 60 | 1 | |
| 17856-0672-1 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-2 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-2 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-3 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-3 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-4 | Ondansetron | 72 in 1 CASE | SOLUTION | 72 | 1 | |
| 17856-0672-4 | Ondansetron | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0672-1 | ML - Milliliter | 17856-0672 | f5b97fd9-6050-46e6-b0da-693821d3938a | 1 | 2026-03-17 |
| 17856-0672-2 | ML - Milliliter | 17856-0672 | 787cc894-2cc2-4952-981c-f67609a087e3 | 1 | 2026-03-17 |
| 17856-0672-3 | ML - Milliliter | 17856-0672 | 53831650-5a50-4e31-9590-1c0ac60dc7ec | 1 | 2026-03-17 |
| 17856-0672-4 | ML - Milliliter | 17856-0672 | 68c3eadb-fcbb-40cc-80d0-0ddc4021b83a | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SODIUM PHENYLACETATE and SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Ailex Pharmaceuticals, LLC | 329655ae-c3c0-46b2-a925-e49777f2076b | 2025-03-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Addiclenz | ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, BETA VULGARIS, BISPHENOL A, BOLDO, CHELIDONIUM MAJUS, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PETROSELINUM SATIVUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, TARAXACUM OFFICINALE, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 25036c26-1c21-4e5a-b4db-b8e177458341 | 2025-03-11 | Warnings | OJ245FE5EU |
| Curist Hemorrhoid Fissure Relief | LIDOCAINE | Little Pharma, Inc | 2fb02b00-acdb-5184-e063-6294a90ae1c8 | 2025-03-06 | Warnings | PDC6A3C0OX |
| Thera Plus Hemorrhoidal | GLYCERIN, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE | FOURSTAR GROUP USA, INC. | 87143a7a-7b2d-4b67-afda-2355697e7300 | 2025-03-04 | Warnings | PDC6A3C0OX |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2025-02-28 | Warnings | PDC6A3C0OX |
| Alcostat | TARAXACUM OFFICINALE, AVENA SATIVA, PASSIFLORA INCARNATA, AURUM METALLICUM, CAPSICUM ANNUUM, CHELIDONIUM MAJUS, LACHESIS MUTUS, LYCOPODIUM CLAVATUM, NOX VOMICA, QUERCUS GLANDIUM SPIRITUS, SULPHURICUM ACIDUM, ETHYLICUM, CARCINOSIN, SACCHARUM OFFICINALE | Energique, Inc. | 77daea02-3c32-4ba3-a7a8-af79b13ddc06 | 2025-02-27 | Warnings | C151H8M554 |
| Blink Nourish Dry Eye | GLYCERIN | Bausch & Lomb Incorporated | cf2b4e19-af0a-472e-9a2d-9b4fa3e9c9a4 | 2025-02-25 | Warnings | PDC6A3C0OX |
| Ondansetron | ONDANSETRON | NuCare Pharmaceuticals, Inc. | 2eeb3c61-4ce9-d8ed-e063-6294a90a00d3 | 2025-02-24 | Warnings, Adverse reactions | NMH84OZK2B |
| Bestmade Natural Products BM164 | ACID PHOS, ARUM TRYPH, BALSAMUM PERU, CAUSTICUM, EQUISETUM, GLYCERINUM, HELONIAS DIO | Bestmade Natural Products | 2e6e49aa-278e-5499-e063-6394a90a999c | 2025-02-18 | Warnings | PDC6A3C0OX |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Omnivium Pharmaceuticals LLC | 9067c301-74f9-457a-9b0f-b7e9b06a3508 | 2025-02-15 | Warnings, Adverse reactions | OJ245FE5EU |
| Hydropure Lubricating Eye Drops | GLYCERIN | OTE North America | 17f5b6e5-dc14-45c7-e063-6294a90af43d | 2025-02-14 | Warnings | PDC6A3C0OX |
| Tyson 2.0 Mike Red Eye Drops For Dry High Eyes | GLYCERIN, NAPHAZOLINE HCL | Jbrands Pharma L.L.C. | 288e9c85-0562-89bf-e063-6394a90a110d | 2025-02-07 | Warnings | PDC6A3C0OX |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | f8ada0e4-5c1b-17ab-e053-6294a90a12b8 | 2025-02-06 | Warnings, Adverse reactions | NMH84OZK2B |
| AN12 Secret Therapy Feminine Cleanser | GLYCERIN | BESTVALUE Co., Ltd | d2117c4c-9f1a-3a6e-e053-2995a90a0cc8 | 2025-01-31 | Warnings | PDC6A3C0OX |
| AN12 Skin Therapy Vita-B Aloe Soothing Gel | GLYCERIN | BESTVALUE Co., Ltd | d274c973-057d-1c9f-e053-2995a90a82b1 | 2025-01-31 | Warnings | PDC6A3C0OX |
| AN12 ANUS PREMIUM CLEANSER | GLYCERIN, ALLANTOIN | BESTVALUE Co., Ltd | d11b7443-2dfc-3e17-e053-2a95a90afb76 | 2025-01-31 | Warnings | PDC6A3C0OX |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Asclemed USA, Inc. | 65b0b2e2-37fd-4d08-9674-954d62bb531a | 2025-01-27 | Warnings, Adverse reactions | NMH84OZK2B |
| Sodium Citrate w/v Anticoagulant | TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | c9d0e9c8-379f-4895-b272-329efab575c4 | 2025-01-24 | Warnings, Adverse reactions | B22547B95K |
| Sodium Citrate 4% w/v Anticoagulant | TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | 0775912f-f14a-4967-ac00-c8c1b36040bf | 2025-01-23 | Warnings, Adverse reactions | B22547B95K |
| Anise Pyrite | ANISE PYRITE | Uriel Pharmacy Inc. | a03cdeb0-8347-40cc-8d17-5510d99575c7 | 2025-01-22 | Warnings | C151H8M554 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.